KCM
IRWD icon

Kennedy Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Kennedy Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-102,477
Closed -$422K – 706
2024
Q3 		$422K Sell
102,477
-1,339
-1% -$7.2K 0.01% 644
2024
Q2 		$677K Sell
103,816
-12,727
-11% -$90K 0.01% 621
2024
Q1 		$1.02M Buy
116,543
+10,645
+10% +$129K 0.02% 619
2023
Q4 		$1.21M Buy
+105,898
New +$1.05M 0.03% 569

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Kennedy Capital Management's IRWD Position: Q4 2024 in Review

Kennedy Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2024, closing a stake of 102,477 shares — an estimated $422K sold.

Kennedy Capital Management first reported a position in IRWD in Q4 2023 and held it in 4 quarters. The position peaked at $1.21M in Q4 2023. 223 funds tracked by Wall St. Rank hold IRWD as of Q4 2024.

  • Kennedy Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Kennedy Capital Management sold 102,477 Ironwood Pharmaceuticals shares in Q4 2024, an estimated $422K.
  • Kennedy Capital Management first reported a position in Ironwood Pharmaceuticals in Q4 2023 and held it in 4 quarters.
  • Kennedy Capital Management's Ironwood Pharmaceuticals position peaked at $1.21M in Q4 2023.
  • 223 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2024.

Based on Kennedy Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.